Table of Content - Myopia And Presbyopia Eye Drops Market

Presbyopia is an eye disorder, in which one’s eyes gradually lose the ability to see things clearly up close distances. It is a normal part of aging. In addition, myopia is a common eye disorder that cause vision loss, and uncorrected myopia is amongst the leading cause of distance vision impairment worldwide. Several individual studies have shown variations in the prevalence of high myopia and myopia in regions and ethnic groups, and there continues to be uncertainty regarding increasing prevalence of myopia. Moreover, market players are focused on inorganic strategies such as partnerships, in order to increase awareness about childhood myopia which in turn is expected to boost the market growth over the forecast period. For instance, in October 2020, Myopia Profile Pty Ltd and Essilor International entered into a partnership agreement for empowering eye care practitioners with skills, clinical knowledge, and practice in managing childhood myopia. The partnership will also boost public awareness of the consequences of myopia, also called near sightedness, and in addition, this will also encourage parents to have their children’s vision tested.

Market Dynamics

Researchers are focusing on research and development activities for the development of new treatment for myopia and presbyopia, by using new technologies, which is expected to drive growth of the global myopia & presbyopia eye drops market over the forecast period. For instance, in January 2019, Bar-Ilan University’s Institute of Nanotechnology and Advanced Materials (BINA), Israel, developed eye drops called as ‘nanodrops’ for correcting the refractive-related vision problems such as myopia and presbyopia. The eye drops are made up of a synthetic nanoparticle solution and have been tested on pig’s cornea. The researchers reported that the drops treated two kinds of refractive errors: myopia and presbyopia in pigs.

Key features of the study

This report provides an in-depth analysis of the global myopia & presbyopia eye drops market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global myopia & presbyopia eye drops market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals, LENZ Therapeutics, Visus Therapeutics, Ocuphire Pharma Inc., Eyenovia, Inc., Vyluma Inc., and Jawa Pharmaceuticals (India) Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global myopia & presbyopia eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global myopia & presbyopia eye drops market

Market Segmentation

By Eye Drops (Revenue, USD Bn, 2021-2033)
- Atropine Drops
- Pipeline Products
  - CSF-1
  - AGN – 190584
  - Nyxol
  - UNR844-Cl
  - PRX-100
  - MicroLine
  - Others
By Indication (Revenue, USD Bn, 2021-2033)
- Myopia
- Presbyopia
By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Ophthalmic Clinics
- Others
By Region (Revenue, USD Bn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Key Players
- Orasis Pharmaceuticals
- AbbVie Inc. (Allergan)
- Novartis AG
- OSRX Pharmaceuticals
- LENZ Therapeutics
- Visus Therapeutics
- Ocuphire Pharma Inc.
- Eyenovia, Inc.
- Vyluma Inc.
- Jawa Pharmaceuticals (India) Pvt. Ltd.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Eye Drops
  - Market Snapshot, By Indication
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter’s Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
Myopia And Presbyopia Eye Drops Market, By Eye Drops, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Atropine Drops
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Pipeline Products
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
    - CSF-1
    - AGN-190584
    - Nyxol
    - UNR844-Cl
    - PRX-100
    - MicroLine
    - Others
Myopia And Presbyopia Eye Drops Market, By Indication, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Myopia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Presbyopia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
Myopia And Presbyopia Eye Drops Market, By End User, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Ophthalmic Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
Myopia And Presbyopia Eye Drops Market, By Region, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
  - Orasis Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - AbbVie Inc. (Allergan)
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Novartis AG
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - OSRX Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - LENZ Therapeutics
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Visus Therapeutics
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Ocuphire Pharma Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Eyenovia, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Vyluma Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Jawa Pharmaceuticals (India) Pvt. Ltd.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE